Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis.

Chainani-Wu N, Chang C, Gross AJ, Yom SS, Silverman S Jr.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Mar;117(3):e261-3. doi: 10.1016/j.oooo.2013.11.499. Epub 2013 Dec 7.

PMID:
24528797
2.

Atrial fibrillation occurring in a patient taking etanercept plus methotrexate for rheumatoid arthritis.

Wooten MD, Reddy GV, Johnson RD.

Del Med J. 2000 Dec;72(12):517-9.

PMID:
11200291
3.

Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.

Kuroda T, Sato H, Nakatsue T, Wada Y, Murakami S, Nakano M, Narita I.

BMC Res Notes. 2014 Apr 11;7:229. doi: 10.1186/1756-0500-7-229.

4.

Developing of granulomatous thyroiditis during etanercept therapy.

Cañas CA, Tobón GJ, Arango LG, Guarín N.

Clin Rheumatol. 2009 Jun;28 Suppl 1:S17-9. doi: 10.1007/s10067-008-1046-2. Epub 2008 Nov 29.

PMID:
19043773
5.

No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years.

Lebwohl M, Blum R, Berkowitz E, Kim D, Zitnik R, Osteen C, Wallis WJ.

Arch Dermatol. 2005 Jul;141(7):861-4.

PMID:
16027301
6.

Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients.

Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R.

Clin Rheumatol. 2007 Nov;26(11):1969-71. Epub 2007 Mar 6.

PMID:
17340045
7.

Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?

Haroon M, Ryan JG, Harney S.

Clin Rheumatol. 2011 Aug;30(8):1095-8. doi: 10.1007/s10067-011-1704-7. Epub 2011 Mar 8.

PMID:
21380931
8.

Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.

Sweet DD, Isac G, Morrison B, Fenwick J, Dhingra V.

CJEM. 2007 Jan;9(1):40-2.

PMID:
17391602
9.

[Cancer of the cheek in a patient under etanercept].

Rousseau A, Taberne R, Siberchicot F, Fricain JC, Zwetyenga N.

Rev Stomatol Chir Maxillofac. 2009 Nov;110(5):306-8. doi: 10.1016/j.stomax.2009.07.002. French.

PMID:
19836037
10.

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.

N Engl J Med. 1999 Jan 28;340(4):253-9.

11.

Parapharyngeal abscess in a patient receiving etanercept.

Borrás-Blasco J, Nuñez-Cornejo C, Gracia-Perez A, Rosique-Robles JD, Casterá MD, Viosca E, Abad FJ.

Ann Pharmacother. 2007 Feb;41(2):341-4. Epub 2007 Jan 16.

PMID:
17227824
12.

Metastatic bone lesion due to methotrexate and etanercept 24 years after breast cancer treatment.

Yano S.

BMJ Case Rep. 2014 Apr 12;2014. pii: bcr2013202615. doi: 10.1136/bcr-2013-202615.

13.

Therapies for active rheumatoid arthritis after methotrexate failure.

O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E; CSP 551 RACAT Investigators.

N Engl J Med. 2013 Jul 25;369(4):307-18. doi: 10.1056/NEJMoa1303006. Epub 2013 Jun 11.

14.

Giant cell arteritis in a patient taking etanercept and methotrexate.

Seton M.

J Rheumatol. 2004 Jul;31(7):1467. No abstract available.

15.

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.

Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P; 20000223 Study Group.

Arthritis Rheum. 2004 May;50(5):1412-9.

16.

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L.

Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941.

17.

Safety and effectiveness of 6 months' etanercept monotherapy and combination therapy in Japanese patients with rheumatoid arthritis: effect of concomitant disease-modifying antirheumatic drugs.

Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Hirose T, Yoshinaga T, Suzukawa M.

J Rheumatol. 2013 Oct;40(10):1658-68. doi: 10.3899/jrheum.120490. Epub 2013 Aug 1.

PMID:
23908446
18.

[Lung carcinoma in a patient with rheumatoid arthritis treated with tumor necrosis factor antagonist].

Okubo T, Kawada M, Suzuki Y, Kawarada Y, Kitashiro S, Okushiba S.

Kyobu Geka. 2012 Dec;65(13):1147-9. Japanese.

PMID:
23202712
20.

Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.

Sakaida H, Komase Y, Takemura T.

Mod Rheumatol. 2010 Dec;20(6):611-6. doi: 10.1007/s10165-010-0327-1. Epub 2010 Jun 24.

PMID:
20585825

Supplemental Content

Support Center